Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study

BACKGROUND: Uveal melanoma (UM) is the most common intraocular malignancy in adults. In contrast to cutaneous melanoma (CM), there is no standard therapy, and the efficacy and safety of dual checkpoint blockade with nivolumab and ipilimumab is not well defined. METHODS: We conducted a retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Najjar, Yana G, Navrazhina, Kristina, Ding, Fei, Bhatia, Roma, Tsai, Katy, Abbate, Kelly, Durden, Barbara, Eroglu, Zeynep, Bhatia, Shailender, Park, Song, Chowdhary, Akansha, Chandra, Sunandana, Kennedy, Jonathan, Puzanov, Igor, Ernstoff, Marc, Vachhani, Pankit, Drabick, Joseph, Singh, Arun, Xu, Tan, Yang, Jessica, Carvajal, Richard, Manson, Daniel, M Kirkwood, John, Cohen, Justine, Sullivan, Ryan, Johnson, Douglas, Funchain, Pauline, Shoushtari, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319717/
https://www.ncbi.nlm.nih.gov/pubmed/32581057
http://dx.doi.org/10.1136/jitc-2019-000331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319717/
https://www.ncbi.nlm.nih.gov/pubmed/32581057
http://dx.doi.org/10.1136/jitc-2019-000331

Ejemplares similares